EA200701599A1 - Способ и композиция для восстановления сердечной ткани - Google Patents

Способ и композиция для восстановления сердечной ткани

Info

Publication number
EA200701599A1
EA200701599A1 EA200701599A EA200701599A EA200701599A1 EA 200701599 A1 EA200701599 A1 EA 200701599A1 EA 200701599 A EA200701599 A EA 200701599A EA 200701599 A EA200701599 A EA 200701599A EA 200701599 A1 EA200701599 A1 EA 200701599A1
Authority
EA
Eurasian Patent Office
Prior art keywords
restoration
composition
heart tissue
cells
compositions
Prior art date
Application number
EA200701599A
Other languages
English (en)
Inventor
Донни Рудд
Original Assignee
Редженетек, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Редженетек, Инк. filed Critical Редженетек, Инк.
Publication of EA200701599A1 publication Critical patent/EA200701599A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0647Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/193Colony stimulating factors [CSF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/22Colony stimulating factors (G-CSF, GM-CSF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящее изобретение направлено на ИВЭМС-размножение стволовых клеток крови млекопитающего, согласно предпочтительному варианту, клеток CD34+/CD38-, композиции, полученные на основе ИВЭМС-размноженных клеток, и на способ лечения сердечного заболевания либо восстановления сердечной ткани с помощью упомянутых композиций.
EA200701599A 2005-02-28 2006-02-27 Способ и композиция для восстановления сердечной ткани EA200701599A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65728705P 2005-02-28 2005-02-28
PCT/US2006/006829 WO2006093860A2 (en) 2005-02-28 2006-02-27 Method and composition for repairing heart tissue

Publications (1)

Publication Number Publication Date
EA200701599A1 true EA200701599A1 (ru) 2008-04-28

Family

ID=36941686

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200701599A EA200701599A1 (ru) 2005-02-28 2006-02-27 Способ и композиция для восстановления сердечной ткани

Country Status (11)

Country Link
US (1) US20060193836A1 (ru)
EP (1) EP1853301A2 (ru)
JP (1) JP2008531696A (ru)
KR (1) KR20070112205A (ru)
CN (1) CN101166541A (ru)
BR (1) BRPI0608277A2 (ru)
CA (1) CA2599332A1 (ru)
EA (1) EA200701599A1 (ru)
IL (1) IL185557A0 (ru)
MX (1) MX2007010451A (ru)
WO (1) WO2006093860A2 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2599274A1 (en) * 2005-02-28 2006-09-08 Regenetech, Inc. Method of providing readily available cellular material derived from peripheral blood and a composition thereof
US20110076255A1 (en) 2005-11-07 2011-03-31 Pecora Andrew L Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
US8637005B2 (en) 2005-11-07 2014-01-28 Amorcyte, Inc. Compositions and methods of vascular injury repair
EP2441461B1 (en) * 2005-11-07 2014-05-07 Amorcyte, Inc. Compositions and methods of vascular injury repair
US20090081752A1 (en) * 2007-09-24 2009-03-26 Dennis Robert G Bioreactor, kit and method of using same
US8993231B2 (en) * 2008-03-18 2015-03-31 Marshall University Research Corporation Methods for stem cell production and therapy
CN102245189B (zh) 2008-12-03 2015-06-17 阿莫塞特公司 改善梗死区灌注的组合物以及血管损伤修复方法
KR20160075676A (ko) 2013-10-24 2016-06-29 오스페달레 산 라파엘 에스.알.엘. 방법
US9410143B1 (en) 2014-06-10 2016-08-09 Endonovo Therapeutics, Inc. Biological molecules produced by electromagnetically stimulating living mammalian cells
CN111313782B (zh) * 2020-01-20 2022-03-01 江苏新安电器股份有限公司 基于免疫算法的感应电机无源性控制方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192553A (en) * 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5026650A (en) * 1988-06-30 1991-06-25 The United States Of Amercia As Represented By The Administrator Of The National Aeronautics And Space Administration Horizontally rotated cell culture system with a coaxial tubular oxygenator
US5153132A (en) * 1988-06-30 1992-10-06 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Three-dimensional co-culture process
US4988623A (en) * 1988-06-30 1991-01-29 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Rotating bio-reactor cell culture apparatus
US6962698B1 (en) * 1998-02-17 2005-11-08 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
US20020159984A1 (en) * 1999-11-12 2002-10-31 Quality Biological, Inc. Cultivation of cells for long term engraftment
US6485963B1 (en) * 2000-06-02 2002-11-26 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Growth stimulation of biological cells and tissue by electromagnetic fields and uses thereof
AU2002220712A1 (en) * 2000-11-29 2002-06-11 William Rader Stem cells, method for expansion in vitro and use thereof
US20040076620A1 (en) * 2002-09-03 2004-04-22 Donnie Rudd Method of repairing primate mammalian tissue
KR20050086606A (ko) * 2002-11-15 2005-08-30 가부시키가이샤 상가쿠렌케이키코큐슈 장기의 재생 방법
US20050084962A1 (en) * 2003-08-20 2005-04-21 Bruce Simon Methods of treatment using electromagnetic field stimulated stem cells
US20080057042A1 (en) * 2005-01-27 2008-03-06 Donnie Rudd Method of providing readily available cellular material derived from cord blood, and a composition thereof
US20080075700A1 (en) * 2006-02-27 2008-03-27 Wolf David A Method and composition for treating diabetes
US20080050348A1 (en) * 2006-02-27 2008-02-28 Donnie Rudd Method and composition for repairing heart tissue

Also Published As

Publication number Publication date
CA2599332A1 (en) 2006-09-08
BRPI0608277A2 (pt) 2009-11-24
JP2008531696A (ja) 2008-08-14
CN101166541A (zh) 2008-04-23
IL185557A0 (en) 2008-01-06
KR20070112205A (ko) 2007-11-22
MX2007010451A (es) 2007-11-08
WO2006093860A2 (en) 2006-09-08
US20060193836A1 (en) 2006-08-31
WO2006093860A3 (en) 2007-04-12
EP1853301A2 (en) 2007-11-14

Similar Documents

Publication Publication Date Title
EA200701599A1 (ru) Способ и композиция для восстановления сердечной ткани
EA200701600A1 (ru) Способ получения лёгкодоступного клеточного материала из периферической крови и композиция на его основе
EA200701390A1 (ru) Способ получения легкодоступного клеточного материала из пуповинной крови и композиция на его основе
AR109605A2 (es) Método para tratar enfermedades vasculares periféricas, composición y utilización
CY1119853T1 (el) Χρηση στρωματικων βλαστοκυτταρων λαμβανομενων απο ιστο αδιποζης στην θεραπεια συριγγιου
EA200870019A1 (ru) Лактамовые соединения и способы их применения
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
SG146691A1 (en) Methods of preparing and using stem cell compositions and kits comprising the same
NO20092637L (no) Fremgangsmater for behandling
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
NO20045521L (no) Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer
EA200602062A1 (ru) Амидосоединения и их применение в качестве фармацевтических средств
CY1116107T1 (el) Ενωσεις για χρηση στην αγωγη αυτοανοσων παθησεων, ανοσο-αλλεργικων παθησεων και απορριψης μεταμοσχευσης οργανων ή ιστων
ATE395924T1 (de) Wiederherstellung zerstörten gewebes mit hilfe von multipotenten zellen
EA200970335A1 (ru) Композиции и способы для диагностики и лечения рака
EA201000559A1 (ru) Композиции и способы применения антител к склеростину
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
EA200700058A1 (ru) Соединения, композиции и способы их использования
SG155947A1 (en) Compositions and methods for the diagnosis and treatment of tumor
EA200800726A1 (ru) Введение ингибиторов дипептидилпептидазы
NO20091413L (no) WNT-antagonister og deres anvendelse i diagnostiseringen og behandlingen av WNT-medierte forstyrrelser
UA83311C2 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
EA200970110A1 (ru) Производные 6,9-дизамещённого пурина и их применение для лечения кожи
EA200701995A1 (ru) Способы уменьшения кальцификации